Seqirus USA INC.:1334893 [21-002112]01-influenza virus vaccine - quadrivalent influenza vaccine 0.5 ML pre-filled syringes (2021-2022, flucelvax, 10 syringes per box)
Ended Awarded Last action
- Contract number
- 75N90021F00001
- Awardee
-
Seqirus USA Inc. UEI N6U7P2B9VHS5
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $277,576
Award facts
- Contract value 100% obligated
- $277,576.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Summit, NJ 07901, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $35,190 | |
| Original award | $242,386 |
About this award
Seqirus USA Inc. was awarded a $277,576 firm fixed price contract by the Department of Health and Human Services National Institutes of Health Clinical Center to deliver influenza virus vaccine. Specifically, the contract calls for the delivery of 10-packs of 0.5 ml pre-filled syringes of quadrivalent influenza virus vaccine for the 2021-2022 flu season under the Pharmaceuticals and Drugs Federal Supply Schedule contract. No set-aside designation was used for this award. Performance will take place in Summit, New Jersey by Seqirus USA Inc., with an April 2026 completion date. This supports the NIH Clinical Center's efforts to provide influenza vaccines to patients and staff during flu seasons.
Quick answers
Who was awarded contract 75N90021F00001?
75N90021F00001 was awarded to Seqirus USA Inc. by NIH Clinical Center (National Institutes of Health) on January 8, 2021.
How much is contract 75N90021F00001 worth?
The government has obligated $277,576 on 75N90021F00001.
Is contract 75N90021F00001 an order under another contract?
Yes. 75N90021F00001 is a BPA call under V797D70074-75N90020A00004, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75N90021F00001 competed?
The extent of competition for 75N90021F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award